Merck mRNA Melanoma Vaccine Shows Promise in Reducing RecurrenceOctober 26, 2026 Health 3 Views Merck presented trial data for its mRNA melanoma vaccine showing reduced recurrence and death when combined with an immunotherapy drug.
